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Background: Recent studies showed that overwhelming inflammatory response mediated by the toll-like receptor
(TLR)-related pathway was important in the development of acute lung injury (ALI). The aim of this study was to
determine whether common genetic variation in four genes of the TLR signaling pathway were associated with
sepsis-induced ALI susceptibility and risk of death in Chinese Han population.
Methods: Fourteen tag single nucleotide polymorphisms (tagSNPs) in MyD88, IRAK1, IRAK4 and TRAF6 were
genotyped in samples of sepsis-induced ALI (n = 272) and sepsis alone patients (n = 276), and tested for association
in this case-control collection. Then, we investigated correlation between the associated SNP and the mRNA
expression level of the corresponding gene. And we also investigated correlation between the associated SNP and
tumor necrosis factor alpha (TNF-α) as well as interleukin-6 (IL-6) concentrations in peripheral blood mononuclear
cells (PBMCs) exposed to lipopolysaccharides (LPS) ex vivo. The mRNA expression level was determined using
real-time quantitative Polymerase Chain Reaction (PCR) assays, and concentrations of TNF-α and IL-6 were
measured by enzyme-linked immunosorbent assay (ELISA).
Results: The association analysis revealed that rs4755453, an intronic SNP of TRAF6, was significantly associated with
susceptibility to sepsis-induced ALI. The C allele frequency of rs4755453 in the sepsis alone group was significantly
higher than that in the sepsis-induced ALI group (P= 0.00026, odds ratio (OR) = 0.52, 95% confidence interval (CI)
0.37–0.74). These associations remained significant after adjustment for covariates in multiple logistic regression
analysis and for multiple comparisons. TRAF6 mRNA expression levels in PBMCs from homozygotes of the
rs4755453G allele were significantly higher than that in heterozygotes and homozygotes of the rs4755453C allele at
baseline (P= 0.012 and P= 0.003, respectively) as well as after LPS stimulation (P= 0.009 and P= 0.005). Moreover,
the concentrations of TNF-α and IL-6 in cell culture supernatants were also significantly higher in the subjects with
rs4755453GG genotype than in subjects with CG and CC genotype. None of the 14 tagSNPs showed associations
with risk of death and severity among ALI cases.
Conclusions: Our findings indicated that common genetic variants in TRAF6 were significantly associated with
susceptibility to sepsis-induced ALI in Chinese Han population. This was the first genetic evidence supporting a role
for TRAF6 in ALI.
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Acute lung injury (ALI) and its more severe form, the
acute respiratory distress syndrome (ARDS), are charac-
terized by increased inflammatory cytokine expression
and cell infiltration into the lungs, non-cardiogenic pul-
monary edema, and diffuse alveolar damage that culmi-
nates in respiratory failure [1]. ALI remains an
important cause of death in the intensive care unit
(ICU) and few specific therapies are available [2]. The
causes of ALI are numerous (e.g., pneumonia, sepsis, as-
piration, trauma and pancreatitis), but the reasons why
certain individuals develop lung injury in response to
these stimuli and others do not are not well understood.
There was abundant evidence in the literature that gene-
host and gene-environment interactions might play a
large role in the morbidity and mortality associated with
this syndrome [3,4]. A number of recent studies revealed
that genetic variation might confer risk of developing
ALI or influence ALI mortality [5-19]. To date, genetic
variants in more than 20 genes were found to be asso-
ciated with ALI and ALI-related outcomes.
Although the exact mechanism of ALI/ARDS
remained incompletely understood, it was well estab-
lished that overwhelming inflammation was a fundamen-
tal component of the pathophysiology [2]. TLRs, a
family of immune receptors, are described to be involved
in the recognition of both pathogen-associated molecu-
lar patterns (PAMPs) and damage-associated molecular
patterns (DAMPs). TLR signaling pathway is regulated
by TIR domain-containing adaptors. Upon ligand bind-
ing to TLR, the adaptor molecule Myeloid differentiation
factor 88 (MyD88) is recruited to TLR complex as a
dimer. Then MyD88 recruits interleukin-1 receptor-
associated kinase 1 (IRAK1), IRAK4, and TNF receptor-
associated factor 6 (TRAF6), which results in the activa-
tion of NF-κB and production of inflammatory cytokines
[20]. MyD88, as an adaptor molecule of TLRs, plays an
important role in LPS-induced inflammation. MyD88
knockout mice showed no responses to LPS in terms of
macrophage production of inflammatory mediators [21].
Both IRAK1 and IRAK4 contain an N-terminal death
domain, which is responsible for interaction with
MyD88, and have an essential role in the activation of
NF-κB and MAPK. Animal studies found that IRAK-4
or IRAK1 knockout mice have an impaired response to
various microbial components [22,23]. TRAF6 exhibits
various functions in regulating adaptive and innate im-
munity, and cell apoptosis [24]. The immune response
initiated by TLR signaling pathway is an important
mechanism in defense against pathogenic microorgan-
isms and maintenance of tissue integrity. However, pro-
longed and excessive activation of TLR signaling
pathway causes the overproduction of inflammatory
cytokines and contributes to tissue or organ injury [25].There was increasing evidence that excessive inflamma-
tion mediated by the TLR-related pathway might con-
tribute to the morbidity and mortality of ALI [26].
Several SNPs within genes encoding the activating TLR
signaling pathway were reported to influence the produc-
tion of inflammatory cytokines and be associated with sus-
ceptibility to ALI and sepsis. Two variants in the TLR4
gene, D299G (rs4986790) and T399I (rs4986791), were
associated with susceptibility to sepsis [27]. Recently,
TLR1 -7202A/G (rs5743551) was reported to be corre-
lated with hyper-inflammatory responses to PAMPs and
associated with increased susceptibility to sepsis-induced
ALI and organ dysfunction [28,29]. Two studies showed
that a haplotype in IRAK-1, which increased nuclear levels
of NF-κB, was related to severity and mortality of sepsis
[30,31]. Rs8177374 (S180L), located in TIRAP on chromo-
some 11q24.2, was associated with the risk of invasive
pneumococcal disease and septic shock [32,33]. Pino-
Yanes et al. found that four common variants (rs1732888,
rs1732887, rs1732886 and rs10506481) of the IRAK3 gene
were associated with ALI development during severe sep-
sis [13]. Our latest studies also found two SNPs
(rs8177375 and rs595209) within TIRAP were associated
with the susceptibility to sepsis-induced ALI [34]. How-
ever, the role of genetic variation within downstream
components of the TLR signaling pathway on ALI devel-
opment and mortality remained largely unexplored.
Given the importance of exaggerated inflammatory re-
sponse in the pathogenesis of ALI and the pivotal role of
TLR signaling pathway in inflammatory response, we
hypothesized that genetic variation in the TLR signaling
pathway genes might be associated with susceptibility
and outcome of ALI. To test this hypothesis, we con-
ducted a case-control study using tag SNP approach to
investigate the association of variants in MyD88, IRAK1,
IRAK4 and TRAF6 with susceptibility and outcome of
sepsis-induced ALI in Chinese Han population. In
addition, we performed functional evaluation of the
associated SNP.
Materials and methods
Study design and enrollment
Definitions of sepsis and ALI/ARDS were in accordance
with the American College of Chest Physicians/Society
of Critical Care Medicine Consensus Conference [35]
and the American-European Consensus Conference
statements [36]. All sepsis subjects enrolled had either
severe sepsis or septic shock. All patients were selected
from the Emergency, Surgical and Respiratory ICU at
Zhongshan Hospital, Fudan University. Exclusion cri-
teria included age < 18 years, pregnancy, diffuse alveolar
hemorrhage, severe chronic respiratory disease, directive
to withhold intubation, severe chronic liver disease
(defined as a Child–Pugh score of > 10), malignancy,
Table 1 Characteristics of the genotyped SNPs in the
genes of TLR signaling pathway
Gene SNP Location Major/minor allele HWE P value
MyD88 rs6853 3′ UTR A/G 0.35
rs7744 3′ UTR A/G 0.48
IRAK1 rs1059703 exon C/T 0.45
IRAK4 rs3794262 intron A/T 0.48
rs4251429 intron G/C 0.97
rs4251545 exon G/A 0.75
rs4251569 intron C/T 0.47
rs4251513 intron C/G 0.94
rs4251466 intron C/T 0.39
rs4251431 intron G/T 0.37
rs1461567 intron C/T 0.11
TRAF6 rs540386 intron C/T 1.00
rs4755453 intron G/C 0.32
rs5030493 intron T/A 1.00
SNP, single nucleotide polymorphism; HWE, Hardy-Weinberg equilibrium; UTR,
untranslated region.
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(steroids with equivalent prednisone ≥ 0.5 mg/kg per
day or cytotoxic agents for immunologic disorders) and
AIDS patients. All sepsis patients were screened daily
for ALI/ARDS development and those who fulfilled the
AECC criteria for ALI/ARDS were considered as ALI
cases, which included ALI and ARDS patients; whereas
those patients who did not develop ALI/ARDS during
hospital stay were considered as sepsis alone patients.
Clinical and demographic data at baseline, including
Acute Physiology and Chronic Health Evaluation (APA-
CHE) II scores, organ failure, previous health status,
hospital and ICU mortality were obtained after the pa-
tient met inclusion criteria. Part of the patients included
in the present study overlapped with that in our previ-
ous study [34].
This study was approved by the Ethic Committee of
Zhongshan Hospital, Fudan University, Shanghai, China
(Record no: 2006-23). Informed consent was obtained
from subjects or from their legal surrogates before en-
rollment. Recent analyses by Genome-wide SNP vari-
ation have shown that the central Han Chinese could be
regarded as one single homogenous population [37,38].
To reduce the potential confounding from ethnic back-
grounds, we only enrolled people with self-reported ori-
gin of central Han Chinese, including indigenous people
from Zhejiang Province, Jiangsu Province, Anhui Prov-
ince and Shanghai.
SNPs selection and genotyping
A total of four candidate genes involved in TLR signal-
ing pathway were selected according to the known bio-
logical activity: MyD88, IRAK1, IRAK4 and TRAF6.
TagSNPs were selected on the basis of the Chinese Han
in Beijing data from the HapMap project phase II
(http://www.hapmap.org/) [39]. The tagSNPs covered
the gene regions and up to 1 kb of 3’ as well as 5’ flank-
ing regions of the candidate genes. In total, 14 tagSNPs
in the four genes were selected by tagger implemented
in Haploview using the following tagging criteria: pair-
wise tagging of the HapMap population with r2 of at
least 0.8 and a minor allele frequency of at least 5%. Lo-
cation and characterization of all tested tagSNPs were
listed in Table 1. Among the 14 tagSNPs, two were non-
synonymous.
Genomic DNA was extracted from whole blood with a
FlexiGene DNA Kit (Qiagen, Hilden, Germany) in ac-
cordance with the protocol of the manufacturer. Twelve
tagSNPs in IRAK1, IRAK4 and TRAF6 were genotyped
on the GenomeLab SNPstream high-throughput 12-plex
genotyping platform (Beckman Coulter, Fullerton, CA)
following the manufacturer’s instructions. The primers
for PCR and single base extension were designed by
Beckman Coulter Autoprimer software and were shownin Table S1 in Additional file 1. Two tagSNPs in MyD88
were genotyped by direct sequencing. The sequencing
reactions were performed using Applied Biosystems Big-
Dye (version 3.1) chemistry (Applied Biosystem, Foster
City, CA, USA), and the sequences were resolved using
an ABI 3730 Genetic Analyzer. The primers and PCR
protocols used were shown in Table S2 in Additional file
1. Genotyping was carried out blind to case–control sta-
tus. One duplicate sample was added to each 96-well
sample plate for quality assurance and quality control
validation of inter-plate discordance, and we placed an
extra 10 duplicates into our sample set in order to test
for experiment-wide discordance. The data completion
rate was 99.2%.Isolation and stimulation of cells from healthy subjects
PBMCs were derived from 90 unrelated healthy Chinese
Han volunteers using Ficoll gradient density centrifuga-
tion method. Isolated PBMCs were plated at a density of
1 x 106 cells/ml in 24-well plates and cultured in RPMI
1640 medium with 10% FBS at 37°C with 5% CO2. The
cells were then incubated for 6 hours in presence or ab-
sence of 100 ng/ml Escherichia coli 0111:B4 LPS (Sigma,
USA). After incubation, supernatants and cell pellets
were harvested and stored at −80°C until use.RNA purification and TRAF6 mRNA expression analysis
Total RNA was extracted using RNeasy Mini kit (Qia-
gen, Hilden, Germany). 100 ng RNA was used for
cDNA synthesis using a High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) according to
the manufacturer’s protocol. Quantitative RT-PCR was







Total no. 276 272 N.A
Patient age 63.3 ± 13.8 64.1 ± 12.5 0.65
Male patients 163 (59.1%) 167 (61.4%) 0.58
BMI 21.8 ± 5.4 22.1 ± 8.1 0.14
Smoker 115 (41.7%) 113 (41.5%) 0.98
Liver cirrhosis 7 (2.5%) 8 (2.9%) 0.80
Diabetes 37 (13.4%) 32 (11.8%) 0.56
30-d mortality 110 (39.9%) 142 (52.2%) 0.004
APACHE II score 14.7 ± 7.2 19.6 ± 3.4 <0.001
Organ failure 1.9 ± 0.2 3.1 ± 0.2 <0.001
Transfusion of PRBC 75 (27.2%) 105 (38.6%) 0.004
Number of PRBC transfused 1.2 1.6 0.012
Infection site
Pulmonary source 158 (57.2%) 179 (65.8%) 0.039
Extrapulmonary source 118 (42.8%) 93 (34.2%) 0.039
ALI, acute lung injury; N.A, not applicable; BMI, body mass index; APACHE II,
acute physiology and chronic health evaluation; PRBC, packed red blood cells.
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PRISM 7900 Sequence Detector (Applied Biosystems,
USA) with SDS 2.1 software. Each reaction was per-
formed in triplicate, with final calculations resulting from
means of triplicate wells. The ΔΔCq method was used to
determine the difference for the mean expression levels
of TRAF6 between study subjects with different geno-
types of rs4755453. For each individual, the relative ex-
pression level ΔCq (Cq T - Cq E) of TRAF6 was
normalized with GAPDH and then transformed into rela-
tive quantity using the RQ formula (RQ = 2-ΔΔCq , where
ΔΔCq is for the individual and ΔCq is the calibrator).
The primers for TRAF6 were: forward 5′- AGGGACC-
CAGCTTTCTTTGT-3′ and reverse 5′- GCCAAGT-
GATTCCTCTGCAT-3′. The primers for GAPDH were:
forward 5′-TGAAGGTCGGAGTCAACGGATTTGGT-3′
and reverse 5′-CATGTGGGCCAT GAGGTCCACCAC-3′.
Measurement of TNF-α and IL-6 levels
Concentrations of TNF-α and IL-6 in culture superna-
tants were determined by human ELISA kit (R&D Sys-
tems, USA) according to the manufacturer’s protocol.
Statistical analysis
The genotype data was analyzed for deviations from
Hardy-Weinberg equilibrium by the Haploview v4.1 soft-
ware [40]. Univariate analysis was performed using χ2
test for categorical variables and Student’s t-test for con-
tinuous variables as appropriate. Variables with P < 0.2
were entered into a logistic-regression model using a
backward-selection algorithm. The final model included
gene effect, variables from backward elimination, and
clinically relevant variables such as age, gender, organ
failure, APACHE II score, transfusion of PRBC, number
of PRBC transfused and infection site. The differences of
allele and genotype distributions between case and con-
trol groups were compared using χ2-test or Fisher’s exact
test when appropriate. P values for genotypic distribu-
tions were calculated using the global genotype test. Al-
lele frequencies of cases and controls were used to
calculate the OR and the 95% CI. The Bonferroni
method was used to correct for multiple comparisons
where applicable. A two tailed P-value of < 0.05 was con-
sidered statistically significant, whereas a value of cor-
rected P < (0.05/number of tests), was considered
significant after Bonferroni correction. IRAK1 is X
chromosome linked. We used logistic regression method
including sex as a covariate to analysis the association
with IRAK1 SNPs. For the IRAK1 SNPs, males were
coded as homozygote females in the logistic regression
analysis. Differences in relative mRNA expression, TNF-
α and IL-6 levels among three genotypes were evaluated
by Kruskal-Wallis test. When a significant difference
was obtained in Kruskal-Wallis test, Mann-Whitney Utest was used to identify specific group differences. The
software used for statistical calculations was SPSS 15.0
(SPSS Inc., Chicago, IL, USA) unless specified.Results
Characteristics of the study population
From February 2006 to December 2010, a total of 272
sepsis-induced ALI (66 ALI and 206 ARDS patients) and
276 sepsis alone patients were enrolled in this study.
The baseline characteristics and clinical data of all sub-
jects were shown in Table 2. The mean age was
64.1 years for sepsis-induced ALI patients and 63.3 years
for sepsis alone patients (P > 0.05). The proportion of
male was 61.4% in ALI patients and 59.1% in sepsis
alone patients (P > 0.05). ALI patients had higher average
APACHE II scores and mortality ratio, and more organ
failures than sepsis alone patients (P < 0.01).Association analyses of MyD88, IRAK1, IRAK4 and TRAF6
polymorphisms with susceptibility to sepsis-induced ALI
The allele and genotype distributions of all tagSNPs in
sepsis-induced ALI and sepsis alone patients were listed
in Table 3. The genotyping success rates of all tested
SNPs ranged from 98% to 99%. All the genotyped SNPs
did not diverse significantly from Hardy-Weinberg equi-
librium. The HWE p-values for all tested SNPs in con-
trols and cases were shown in Table 1. Single locus
analysis showed that rs4755453, an intronic SNP of
TRAF6, was significantly associated with risk of ALI,






Allelic Comparison Genotypic Comparison
P Padj OR (95% CI) ORadj (95% CI) P Padj
TRAF6 rs540386 0.24 0.42 0.69 (0.37–1.28) 0.72 (0.42–1.47) 0.23 0.42
CC 248 (90.8%) 250 (93.6%)
TC 25 (9.2%) 17 (6.4%)
C 521 (95.4%) 517 ( 96.8%)
T 25 (4.6%) 17 (3.2%)
rs4755453 0.00026 0.0012 0.52 (0.37–0.74) 0.71 (0.58–0.82) 0.00046 0.0021
GG 181 (66.5%) 215 (80.2%)
CG 81 (29.8%) 51 (19%)
CC 10 (3.7%) 2 (0.75%)
G 446 (81.4%) 481 (89.7%)
C 98 (18.6%) 55 (10.3%)
rs5030493 0.23 0.36 0.78 (0.53–1.17) 0.69 (0.42–1.21) 0.15 0.24
AA 214 (79%) 218 (82%)
TA 53 (19.6%) 48 (18%)
TT 4 (1.5%) 0
A 481 (88.8%) 484 (91%)
T 61 (11.2%) 48 (9%)
MyD88 rs6843 0.98 0.81 1.01 (0.50–2.04) 1.04 (0.62–2.12) 0.98 0.82
AA 256 (94.1%) 254 (94.1%)
AG 16 (5.9%) 16 (5.9%)
A 528 (97.1%) 524 (97%)
G 16 (2.9%) 16 (3%)
rs7744 0.73 0.75 1.04 (0.82–1.33) 1.03 (0.81–1.35) 0.91 0.92
AA 90 (33.3%) 87 (32.5%)
AG 146 (54.1%) 144 (53.7%)
GG 34 (12.6%) 37 (13.8%)
A 326 (60.4%) 318 (59.3%)
G 214 (39.6%) 218 (40.7%)
IRAK4 rs3794262 0.38 0.65 1.16 (0.84–1.61) 1.02 (0.86–1.83) 0.33 0.46
AA 198 (72.8%) 182 (68.2%)
TA 68 (25%) 81 (30.3%)
TT 6 (2.2%) 4 (1.5%)
A 464 (85.3%) 445 (83.3%)
T 80 (14.7%) 89 (16.7%)
rs4251429 0.37 0.58 1.26 (0.76–2.06) 1.13 (0.82–1.93) 0.26 0.52
GG 242 (89.3%) 233 (86.3%)
GC 28 (10.3%) 37 (13.7%)
CC 1 (0.4%) 0
G 512 (94.5%) 503 (93.1%)
C 30 (5.5%) 37 (6.9%)
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Table 3 Association analysis of genetic variation in TRAF6, MyD88,IRAK4 and IRAK1 between sepsis-induced ALI and
sepsis alone patients (Continued)
rs4251545 0.41 0.46 1.18 (0.79–1.77) 1.13 (0.65–1.67) 0.51 0.65
GG 228 (83.5%) 215 (80.2%)
GA 41 (15%) 50 (18.7%)
AA 4 (1.5%) 3 (1.1%)
G 497 (91%) 480 (89.6%)
A 49 (9%) 56 (10.4%)
rs4251569 0.65 0.52 1.09 (0.76–1.56) 1.24 (0.79–2.01) 0.55 0.32
CC 207 (77.2%) 200 (74.6%)
CT 56 (20.9%) 65 (24.3%)
TT 5 (1.9%) 3 (1.1%)
C 470 (87.7%) 465 (86.8%)
T 66 (12.3%) 71 (13.2%)
rs4251513 0.41 0.47 0.90 (0.70–1.15) 0.97 (0.82–1.26) 0.68 0.81
CC 103 (37.7%) 111 (41.4%)
CG 128 (46.9%) 119 (44.4%)
GG 42 (15.4%) 38 (14.2%)
C 334 (61.2%) 341 (63.6%)
G 212 (38.8%) 195 (36.4%)
rs4251466 0.59 0.52 1.12 (0.74–1.69) 1.16 (0.82–1.75) 0.09 0.07
CC 226 (84%) 216 (80.6%)
CT 38 (14.1%) 51 (19%)
TT 5 (1.9%) 1 (0.4%)
C 490 (91.1%) 483 (90.1%)
T 48 (8.9%) 53 (9.9%)
rs4251431 0.79 0.82 0.95 (0.63–1.43) 0.84 (0.76–1.32) 0.39 0.52
GG 224 (82.7%) 221 (82.5%)
GT 43 (15.9%) 46 (17.2%)
TT 4 (1.5%) 1 (0.4%)
G 491 (90.6%) 488 (91%)
T 51 (9.4%) 48 (9%)
rs1461567 0.78 0.81 1.04 (0.81–1.32) 1.02 (0.92–1.25) 0.11 0.23
CC 80 (29.4%) 88 (33%)
TC 136 (50%) 110 (41.2%)
TT 56 (20.6%) 69 (25.8%)
C 296 (54.4%) 286 (53.6%)
T 248 (45.6%) 248 (46.4%)
IRAK1 rs1059703 0.26 0.73 0.70 (0.28–1.74)1 0.78 (0.38–1.69) – –
CC/C- 230 (84.6%) 220 (82.7%)
CT 30 (11%) 38 (14.3%)
TT/T- 12 (4.4%) 8 (3%)
SNP, single nucleotide polymorphism; ALI, acute lung injury; OR, odds ratio; CI, confidence interval.
Data were no. (%) of subjects. P was determined using the chi-square test. Padj and ORadj came from multivariate logistic regression.
A P-value of < 0.0036 (0.05/14) was considered statistically significant after Bonferroni correction.
1 The p value was calculated using logistic regression method including sex as a covariate, in which males were coded as homozygote females.
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Figure 1 Association of TRAF6 mRNA expression levels and
rs4755453 genotype. Expression levels of TRAF6 mRNA in PBMCs
were normalized with GAPDH expression and expressed as the
median, interquartile range and extremes. The mRNA expression
levels were significantly different among GG, GC and CC genotypes
both at baseline (P= 0.002) and under the LPS-stimulated condition
(P= 0.004).
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C allele frequency of rs4755453 in the sepsis alone group
was significantly higher than that in the ALI group
(P= 0.00026, OR= 0.52, 95% CI 0.37–0.74), which
remained significantly after Bonferroni correction
(P= 0.0036, corrected for 14 SNPs tested). Furthermore,
in multivariate analyses after adjustment for age, gender,
organ failure, APACHE II score, transfusion of PRBC,
number of PRBC transfused and infection site,
rs4755453 was still significantly associated with suscepti-
bility to sepsis-induced ALI (Padj = 0.0012, ORadj = 0.71,
95% CI 0.58–0.82). The genotype distributions of
rs4755453 were significantly different between ALI
group and sepsis alone group (P= 0.00046), and the sig-
nificance remained present in a multivariate analysis
controlling for covariates (Padj = 0.0021) and after Bon-
ferroni correction (P= 0.0064, corrected for 14 SNPs
tested) (Table 3). Assuming the prevalence of 0.01 and
using a significance level of 0.05, our study had over
99% power to detect association with rs4755453 (MAF
of 14%) in 272 sepsis-induced ALI vs. 276 sepsis alone
patients. These results implicated the minor allele C has
a protective effect against the development of sepsis-
induced ALI in Chinese Han population.
Association analyses of MyD88, IRAK1, IRAK4 and TRAF6
polymorphisms with ALI severity and mortality
We next tested for associations between all test SNPs
and 30-day mortality. The overall 30-day mortality
among genotyped subjects with ALI was 52.2%. We did
not find association between MyD88, IRAK1, IRAK4 and
TRAF6 variants and 30-day mortality in the ALI cohort
in either the unadjusted or adjusted models (Additional
file 1: Table S3). Then, we made an association analysis
in ALI patients to explore the relation of MyD88, IRAK1,
IRAK4 and TRAF6 variants and ALI severity. The allele
and genotype frequencies of all tagSNPs were not signifi-
cantly different between ALI and ARDS groups (Add-
itional file 1: Table S4). Moreover, no significant
difference was found between MyD88, IRAK1, IRAK4
and TRAF6 variants and P/F ratio (P > 0.05). Taken to-
gether, our results suggested that the variation in
MyD88, IRAK1, IRAK4 and TRAF6 had no effect on the
severity and mortality of ALI.
Association analyses of TRAF6 mRNA expression levels
with rs4755453 genotype
To determine the association between rs4755453 geno-
type and TRAF6 mRNA levels in PBMCs, we selected 44
subjects with rs4755453GG genotype; 30 subjects with
GC genotype and 16 subjects with CC genotype, who
were matched for age and sex. As shown in Figure 1, the
TRAF6 mRNA expression in PBMCs was significantly
higher in GG homozygotes compared with both GCheterozygotes and CC homozygotes both at baseline
(P= 0.012 and P= 0.003, respectively) and after stimula-
tion with LPS for 6 hrs (P= 0.009 and P= 0.005, respect-
ively), whereas the difference between the GC and CC
groups was not statistically significant.
Association analyses of TNF-α and IL-6 levels with
rs4755453 genotype
To determine whether rs4755453 genotypes influenced
the inflammatory cytokine production, we investigated
the TNF-α and IL-6 levels in cell culture supernatants of
PBMCs. We observed a significant association between
TNF-α and IL-6 levels and rs4755453 genotypes. Sub-
jects with homozygotes for rs4755453G allele were asso-
ciated with higher levels of TNF-α and IL-6 compared
with heterozygotes and homozygotes for the rs4755453C
allele both at baseline (P= 0.012 and P= 0.002 for TNF-
α; P= 0.009 and P= 0.004 for IL-6, respectively) and after
LPS stimulation (P= 0.015 and P= 0.002 for TNF-α;
P = 0.014 and P= 0.003 for IL-6, respectively) (Figures 2
and 3).
Discussion
To our knowledge, this was the first study to report the
potential role for genetic variation of TRAF6 with
sepsis-induced ALI susceptibility in Chinese Han popu-
lation. We identified an intronic SNP (rs4755453)
strongly associated with the development of sepsis-
Figure 2 Association of TNF-α levels and rs4755453 genotype.
Concentrations of TNF-α in culture supernatants were expressed as the
median, interquartile range and extremes. The TNF-α levels were
significantly different among GG, GC and CC genotypes both at
baseline (P=0.002) and under the LPS-stimulated condition (P=0.003).
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However, we observed no associations between variants
in these four genes and ALI mortality in this study.Figure 3 Association of IL-6 levels and rs4755453 genotype.
Concentrations of IL-6 in culture supernatants were expressed as the
median, interquartile range and extremes. The IL-6 levels were
significantly different among GG, GC and CC genotypes both at
baseline (P=0.003) and under the LPS-stimulated condition (P=0.003).Taken together, our findings clearly demonstrated a gen-
etic predisposition that greater TRAF6 mRNA expres-
sion might increase susceptibility to sepsis-induced ALI
in the presence of clinical risk factors.
TLRs recognized conserved PAMPs or DAMPs and
then initiated innate immunity response, which contrib-
uted to the overwhelming proinflammatory cytokine
generation. A growing body of literature implicated that
TLRs and their downstream components played an im-
portant role in the pathogenesis of ALI [25,41]. TRAF6
played a critical role in the TLR-mediated signaling
pathway [42]. Liu et al. found that TRAF6 knockdown
resulted in reduced TNF-α and IL-6 mRNA expression
and promoted cell survival upon LPS challenge in pri-
mary rat proximal renal tubular cells [24]. Two studies
found that greater activation of TRAF6 led to significant
increase of the cytokines production and induced the
chronic lung injury [43,44]. Similarly, Imai and collea-
gues found that inactivation of TRAF6 in TRAF6MC-KO
mice alleviated the degree of ALI by inhibiting the ex-
pression of IL-6. And two experimental ALI models in
their study also proved that innate immune signaling via
TLR4-TRIF-TRAF6 was a key genetic pathway that
determined the susceptibility to acute lung failure [26].
Although several variants in the TLR signaling pathway
genes were implicated in susceptibility to ALI and sepsis,
the effect of variation in TRAF6 on human diseases sus-
ceptibility was not reported till now.
How might TRAF6 variant (rs4755453) affect suscepti-
bility to ALI? Our functional study showed that the risk
allele (rs4755453G) was associated with increased TRAF6
mRNA expression and TNF-α and IL-6 production at
baseline and after innate immune stimulation with LPS.
Therefore, it was possible that rs4755453 influenced the
expression of TRAF6 mRNA, and subsequently increased
the production of inflammatory cytokines, which directly
induced lung tissue injury. As an intron polymorphism,
the exact mechanism of rs4755453 induced a phenotypic
change was currently unclear. Rs4755453 is located in the
first intron region of TRAF6. Whether this variation influ-
ences TRAF6 mRNA stability and translation directly,
induces exon skipping, enhances the use of cryptic splice
sites or alters the ratio of alternatively spliced isoforms is
needed to be investigated in future studies.
Rs1059703 (-1595C/T), tagged the IRAK1 functional
haplotype, was found to be associated with exaggerated
NF-κB activation both in vitro and in vivo. In the Cauca-
sian population, this functional haplotype was demon-
strated to be associated with the severity of pulmonary
injury, the risk of septic shock, higher mortality rate of
sepsis and the need for prolonged mechanical ventilation
[30,31]. However, in our data, rs1059703 was not asso-
ciated with susceptibility to ALI, higher mortality rate
and ventilator-free days even in the subgroup of patients
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contribute to such discrepancy. The allele and genotype
distributions of rs1059703 were different between these
two ethnicities. The risk C allele frequency of rs1059703
in Han Chinese descent (87.5%) from Hapmap data was
significantly higher than that in Europeans descent
(18.9%). Allele frequency might reflect the different nat-
ural selection or infection pressures [32]. In addition,
clinical heterogeneity might also contribute to this dis-
crepancy. The individuals served as cases in the two
Caucasian studies were sepsis patients. However, the
cases enrolled in our study were ALI patients caused by
severe sepsis and septic shock.
Our study had several clear strengths. First, sepsis
alone patients who did not develop ALI/ARDS were
served as controls in our study. Such controls were pre-
ferable to healthy individuals since a proportion of
healthy subjects might develop ALI/ARDS under the
stimulus for lung injury. Second, to minimize racial ad-
mixture, we focused on central Han Chinese patients,
which could be regarded as one single homogenous
population. Of note, there were two limitations in the
current study. First, although we have adequate power
to detect rs4755453 association with sepsis induced-ALI
using the current data, independent samples were still
needed to validate the associations. Second, it was pos-
sible that rs4755453 serves as a marker for an as-yet un-
known functional variant within the TRAF6 gene.
Exhaustive re-sequencing should be performed to find
or rule out the possibility of an as-yet-unidentified causal
SNP in linkage disequilibrium with rs4755453.
Conclusions
We reported for the first time that a tag SNP, in the in-
tron region of TRAF6, was associated with sepsis-
induced ALI susceptibility in Chinese Han population.
These findings might have important implications in our
understanding the pathophysiology of ALI and the role
of genetic variation on the development of this lethal re-
spiratory syndrome. However, as this was the first study
to report the genetic variation in TRAF6 and ALI risk,
future studies were needed to validate the associations in
other populations.
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